Report Summary
Eternity Insights has published a new study on Global Female Contraceptives Market focusing on key segments as by Type (Contraceptive Drugs, Contraceptive Devices, Other), by Application (Personal use, Hospital, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Female Contraceptives Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Female Contraceptives Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Female Contraceptives Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Female Contraceptives Market Segmentation:
Female Contraceptives Market, By Type
- Contraceptive Drugs
- Contraceptive Devices
- Other
Female Contraceptives Market, By Application
- Personal use
- Hospital
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Female Contraceptives market in terms of demand generation. The Female Contraceptives market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Female Contraceptives market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Female Contraceptives Market Taxonomy:
To learn more about this report
Global Female Contraceptives Market Competitive Landscape
The global Female Contraceptives market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Bayer
- Mayer Laboratories
- Pfizer
- Mylan
- Teva
- Merck
- Johnson & Johnson
- Lupin Pharmaceuticals
- Female Health Company
- Fuji Latex
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Contraceptive Drugs, Contraceptive Devices, Other |
| By Application Outlook |
Personal use, Hospital, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals, Female Health Company, Fuji Latex |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Female Contraceptives Market Size Growth Rate by Type (2014-2025)
1.4.2 Contraceptive Drugs
1.4.3 Contraceptive Devices
1.5 Market by Application
1.5.1 Global Female Contraceptives Market Share by Application (2014-2025)
1.5.2 Personal use
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Female Contraceptives Market Size
2.2 Female Contraceptives Growth Trends by Regions
2.2.1 Female Contraceptives Market Size by Regions (2014-2025)
2.2.2 Female Contraceptives Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Female Contraceptives Market Size by Manufacturers
3.1.1 Global Female Contraceptives Revenue by Manufacturers (2017-2020)
3.1.2 Global Female Contraceptives Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Female Contraceptives Market Concentration Ratio (CR5 and HHI)
3.2 Female Contraceptives Key Players Head office and Area Served
3.3 Key Players Female Contraceptives Product/Solution/Service
3.4 Date of Enter into Female Contraceptives Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Female Contraceptives Market Size by Type (2017-2020)
4.2 Global Female Contraceptives Market Size by Application (2017-2020)
5 United States
5.1 United States Female Contraceptives Market Size (2017-2020)
5.2 Female Contraceptives Key Players in United States
5.3 United States Female Contraceptives Market Size by Type
5.4 United States Female Contraceptives Market Size by Application
6 Europe
6.1 Europe Female Contraceptives Market Size (2017-2020)
6.2 Female Contraceptives Key Players in Europe
6.3 Europe Female Contraceptives Market Size by Type
6.4 Europe Female Contraceptives Market Size by Application
7 China
7.1 China Female Contraceptives Market Size (2017-2020)
7.2 Female Contraceptives Key Players in China
7.3 China Female Contraceptives Market Size by Type
7.4 China Female Contraceptives Market Size by Application
8 Japan
8.1 Japan Female Contraceptives Market Size (2017-2020)
8.2 Female Contraceptives Key Players in Japan
8.3 Japan Female Contraceptives Market Size by Type
8.4 Japan Female Contraceptives Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Female Contraceptives Market Size (2017-2020)
9.2 Female Contraceptives Key Players in Southeast Asia
9.3 Southeast Asia Female Contraceptives Market Size by Type
9.4 Southeast Asia Female Contraceptives Market Size by Application
10 India
10.1 India Female Contraceptives Market Size (2017-2020)
10.2 Female Contraceptives Key Players in India
10.3 India Female Contraceptives Market Size by Type
10.4 India Female Contraceptives Market Size by Application
11 Central & South America
11.1 Central & South America Female Contraceptives Market Size (2017-2020)
11.2 Female Contraceptives Key Players in Central & South America
11.3 Central & South America Female Contraceptives Market Size by Type
11.4 Central & South America Female Contraceptives Market Size by Application
12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Female Contraceptives Introduction
12.1.4 Bayer Revenue in Female Contraceptives Business (2017-2020)
12.1.5 Bayer Recent Development
12.2 Mayer Laboratories
12.2.1 Mayer Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Female Contraceptives Introduction
12.2.4 Mayer Laboratories Revenue in Female Contraceptives Business (2017-2020)
12.2.5 Mayer Laboratories Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Female Contraceptives Introduction
12.3.4 Pfizer Revenue in Female Contraceptives Business (2017-2020)
12.3.5 Pfizer Recent Development
12.4 Mylan
12.4.1 Mylan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Female Contraceptives Introduction
12.4.4 Mylan Revenue in Female Contraceptives Business (2017-2020)
12.4.5 Mylan Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Female Contraceptives Introduction
12.5.4 Teva Revenue in Female Contraceptives Business (2017-2020)
12.5.5 Teva Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Female Contraceptives Introduction
12.6.4 Merck Revenue in Female Contraceptives Business (2017-2020)
12.6.5 Merck Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Female Contraceptives Introduction
12.7.4 Johnson & Johnson Revenue in Female Contraceptives Business (2017-2020)
12.7.5 Johnson & Johnson Recent Development
12.8 Lupin Pharmaceuticals
12.8.1 Lupin Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Female Contraceptives Introduction
12.8.4 Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2017-2020)
12.8.5 Lupin Pharmaceuticals Recent Development
12.9 Female Health Company
12.9.1 Female Health Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Female Contraceptives Introduction
12.9.4 Female Health Company Revenue in Female Contraceptives Business (2017-2020)
12.9.5 Female Health Company Recent Development
12.10 Fuji Latex
12.10.1 Fuji Latex Company Details
12.10.2 Company Description and Business Overview
12.10.3 Female Contraceptives Introduction
12.10.4 Fuji Latex Revenue in Female Contraceptives Business (2017-2020)
12.10.5 Fuji Latex Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
